Zynex receives fda clearance for its next generation nmes device

Englewood, colo. , feb. 6, 2024 /prnewswire/ -- zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has received clearance from the u.s. food and drug administration ("fda") for the next generation m-wave neuromuscular electrical stimulation ("nmes") device.
ZYXI Ratings Summary
ZYXI Quant Ranking